Selective Toll--like receptor expression in human fetal lung

Area of Science:

• Immunology
• Developmental Biology
• Pulmonology

Background:

• Toll-like receptors (TLRs) are key innate immune sensors involved in inflammatory responses.
• Dysregulation of TLRs is implicated in neonatal inflammatory pulmonary diseases.
• The developmental expression of TLRs in the human fetal lung remains largely undescribed.

Purpose of the Study:

• To characterize the ontogeny of Toll-like receptor (TLR)-related genes in the developing human fetal lung.
• To identify specific TLRs involved in fetal lung development and inflammation.
• To provide insights for potential therapeutic strategies targeting fetal lung inflammation.

Main Methods:

• Analysis of 84 TLR-related genes in 23 human fetal lung samples across three developmental stages (60, 90, and 130 days).
• Utilized a false detection rate algorithm to identify developmentally regulated genes.
• Confirmed Toll-like receptor 2 (TLR2) up-regulation using fluorogenic polymerase chain reaction (TaqMan) assay on 133 additional samples.

Main Results:

• 32 out of 84 examined TLR-related genes showed significant developmental regulation.
• Toll-like receptor 2 (TLR2) exhibited the most substantial up-regulation (9.2-fold increase) among TLR genes.
• Toll-like receptor 4 (TLR4) expression remained unchanged during fetal lung development.
• An exponential best-fit curve indicated a 6.1-fold increase in TLR2 expression from 60 to 130 days.

Conclusions:

• Toll-like receptor 2 (TLR2) is developmentally expressed in the human fetal lung, increasing from the pseudoglandular to the canalicular stage.
• The ontogeny of TLR2 suggests a role in lung development and potential involvement in neonatal inflammatory conditions.
• Understanding TLR2 developmental expression may offer targets for managing fetal inflammatory lung diseases.